Engano, Rovelyn T.
HRN: 17-83-03 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2026
CEFUROXIME 1.5GM (VIAL)
06/28/2026
06/28/2026
IV
1.5 Grams
Q8 X 3 Doses
SP NSD W RMLE
Checking Initial Appropriateness
06/28/2026
CEFUROXIME 500MG (TAB)
06/29/2026
07/06/2026
PO
1 Tab
BID
SP NSD W RMLE
Checking Initial Appropriateness